SCHEMBL8220380

SCHEMBL8220380

CC(C)(C)C1C=C(CCc2ccc(NS(C)(=O)=O)cc2)C(C#N)=C(c2ccc[nH]c2=O)N1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.47
DRD3 P35462 2/20 0.32
DRD2 P14416 1/20 0.32
GRIN1 Q05586 1/20 0.31
GRIN2B Q13224 1/20 0.31
KDM4E B2RXH2 1/20 0.31
ALDH1A1 P00352 1/20 0.31
LMNA P02545 1/20 0.31
HPGD P15428 1/20 0.31
HTT P42858 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
CTSS P25774 1/20 0.31
BRD4 O60885 1/20 0.31
EP300 Q09472 1/20 0.31
CACNA1F O60840 1/20 0.30
CHRM2 P08172 1/20 0.30
ACHE P22303 1/20 0.30
AGTR1 P30556 1/20 0.30
CACNA1D Q01668 1/20 0.30
KCNH2 Q12809 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8219710 0.87 CYP3A4 (0.49) CYP3A4DRD3GRIN1GRIN2BKDM4E
SCHEMBL1542738 0.71 CYP3A4 (0.59) CYP3A4
SCHEMBL8222879 0.71 CYP3A4 (0.51) CYP3A4BRD4EP300
SCHEMBL8221451 0.70 MCL1 (0.34)
SCHEMBL1346748 0.69 CYP3A4 (0.55) CYP3A4GRIN1GRIN2BKDM4ELMNA
SCHEMBL1542619 0.69 CYP3A4 (0.67) CYP3A4KDM4EALDH1A1LMNAHPGD
SCHEMBL8219892 0.67 CYP3A4 (0.50) CYP3A4BRD4EP300
SCHEMBL1542324 0.66 CYP3A4 (0.62) CYP3A4EP300
SCHEMBL1542367 0.66 CYP3A4 (0.62) CYP3A4EP300
SCHEMBL1542382 0.64 CYP3A4 (0.59) CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2480533-A1 HETEROCYCLIC ANTIVIRAL COMPOUNDS F. Hoffmann-La Roche AG (CH) 2012-08-01 EP claimed
WO-2011033045-A1 HETEROCYCLIC ANTIVIRAL COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2011-03-24 WO claimed
EP-2480533-A1 HETEROCYCLIC ANTIVIRAL COMPOUNDS F. Hoffmann-La Roche AG (CH) 2012-08-01 EP disclosed
WO-2011033045-A1 HETEROCYCLIC ANTIVIRAL COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2011-03-24 WO disclosed